Bibiana I. Ferreira

This study compares tumor resistance between Acomys and Mus mice after carcinogen treatment, finding Acomys upregulates tumor suppressor genes and immune-related processes.

This paper identifies a FOXO/Tribbles mRNA signature that predicts poor survival in glioma patients, particularly in grade 4 gliomas, across multiple cohorts.

This study shows TRIB2 promotes glycolysis in melanoma cells, contributing to therapy resistance and suggesting it as a potential therapeutic target.

This study identifies CDK12/13 as key regulators of TRIB2 stability in melanoma and presents three classes of compounds that effectively eliminate TRIB2 with higher potency than afatinib.